Metabolic changes in hypertensive patients treated by low-intensity microwave therapy
https://doi.org/10.18705/1607-419X-2018-24-2-206-216
Abstract
Background. Hypertension (HTN) associated with metabolic syndrome is an important issue of preventive medicine. The modulation of biochemical activity of immune cells might be a solution, as immune cells play crucial role in atherosclerosis progression and vascular inflammation. Among factors regulating molecular processes, e. g. activity of signaling pathways and cell proinflammatory sensitivity, low-intensity microwave (1GHz) therapy attracts attention. The purpose of this study was the assessment of the low-intensity microwave therapy in the management of hypertensive patientsin order to influence the biochemical components of metabolic syndrome. Design and methods. In a randomized double-blinded controlled study, we included 60 patients with hypertension (HTN) aged 45–55 years old. The patients of the comparison group (n = 30) received medication therapy according to the current guidelines, while patients from the study group (n = 30) additionally underwent physiotherapy with the use of microwave therapy (frequency 1 GHz, device “Aquaton”). Control group included 15 otherwise healthy subjects. Serum insulin, glucagon, apoA1 and apoB100 were measured by immuneenzyme assay. Hugh-sensitive C‑reactive potein (hsCRP) was assessed to evaluate the inflammatory response. Results. HTN patients compared to the healthy group demonstrated higher levels of insulin by 23,0% (p = 0,051), apoВ100 by 35,1% (p = 0,001), hsCRP by 43,4% (p = 0,05), and lower levels of glucagon by 5,0% (p = 0,8) and apoА1 by 32,8% (p = 0,000002). Patients of the comparison group who received only medication therapy showed an increase in glucagon level by 2,2% (p = 0,018), apoА1 by 0,96% (p = 0,063), insulin by 3,5% (p = 0,11) with the decrease in apoВ100 by 2,7% (p = 0,083) and hCRP by 2,4% (p = 0,18). Those who additionally underwent the low-intensity microwave therapy showed an increase in glucagon by 1,3% (p = 0,028), apoА1 by 11,1% (p = 0,028), while insulin level decreased by 5,1% (p = 0,06), apoВ100 by 5,4% (p = 0,015) and hsCRP by 5,3% (p = 0,05). There was no significant impact of microwave therapy on the central hemodynamics. Conclusions. The patients who received low-intensity microwave therapy demonstrate higher apoА1 level and lower levels of insulin, apoВ100 and hsCRP. The number of patients to be treated for the planned effect achievement was the following: for the change in the levels of apoА1 — 2,0 patients, change in insulin level — 3,7, change in апоВ100 level — 5,5, change in hsCRP — 5,8. Therefore, low-intensity microwave therapy positively affects metabolism in HTN patients without significant impact in central hemodynamics.
About the Authors
A. A. KhadartcevRussian Federation
MD, PhD, DSc, Professor, Director, Medical Institute, Tula State University, Head, Department of Internal Diseases
A. V. Logatkina
Russian Federation
MD, Postgraduate Student, Department of Internal Diseases, Tula State University
I. V. Terekhov
Russian Federation
MD, PhD, Associate Professor, Department of General Pathology
S. S. Bondar
Russian Federation
MD, Postgraduate Student, Department of Internal Diseases
References
1. Morbidity of population by main classes, groups and diseases. Health care in Russia. 2015: Stat. proceedings of the Rosstat. Moscow, 2015. 176 p. [accessed 2017 Jun 24]. Available from: http: www.gks.ru/free_doc/doc_2015/zdrav15.pdf. In Russian
2. Rydén L, J. Grant P, D. Anker S, Berne C, Cosentino F, Danchin N. ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Russian Journal of Cardiology. 2014;(3):7–61. doi:10.15829/1560-4071-2014-3-7-61 In Russian
3. Makisheva RT. Cellular damage in diabetes is caused by excess insulin action. Bulletin of new medical technologies. The electronic edition. 2016; 1: Publication 2–4 [accessed 2016 Feb 09]. Available from: http://www.medtsu.tula.ru/VNMT/Bulletin/E2016– 1/2–4.pdf. In Russian
4. Umetov MA, Inarokova AM, Khadzegova SA, Vok EK, Kodzoev ZM. Methabolic and immune aspects of cardiovascular disease in car drivers. Russian Journal of Cardiology. 2004; (1):24–27. doi:10.15829/1560-4071-2004-1-24-27 In Russian
5. Uzbekova NR, Khuzhamberdiev MA, Tashtemirova IM. Interaction between sympatho-adrenal activity and immune mediators in patients with metabolic syndrome. Russian Journal of Cardiology. 2014;(3):72–75. doi:10.15829/1560-4071-2014-3-72-75 In Russian
6. Chumakova GA, Veselovskaya NG, Gritsenko OV, Ott AV. Metabolic syndrome: challenging and unresolved issues. Russian Journal of Cardiology. 2014;(3):63–71. doi:10.15829/1560-4071-2014-3-63-71 In Russian
7. Rotar OP, Boyarinova MA, Moguchaya EV, Kolesova EP, Erina AM, Solntsev VN et al. Association of the metabolic syndrome constituents with markers of subclinical target organ damage during follow-up of intellectual laborers. Russian Journal of Cardiology. 2015;(9):38–43. doi:10.15829/1560-4071-2015-9-38-43 In Russian
8. Arleyevsky IP, Chernova OA, Ganeyeva LA, Safin IN, Chernov VM. Mycoplasma spp. Infections and myocardial infarction. Russian Journal of Cardiology. 2003;(4):17–23. doi:10.15829/1560-4071-2003-4-17-23 In Russian
9. Khadartcev AA, Morozov VN, Kropachev AG. Depression anti-stress mechanisms as a basis for the development of the pathological process. Fundamental Research. 2012;(4–2): 371–375. In Russian
10. Khadartcev AA, Belyaeva EA, Borisova ON, Atlas EE. The possibility of external control of physiological and pathological processes in the human body (brief review). Bulletin of new medical technologies. The electronic edition. 2015;(3):8–2 [Accessed 2015 Sep 28]. Available from: http://www.medtsu.tula.ru/VNMT/Bulletin/E20153/5244.pdf. doi:10.12737/13371. In Russian
11. Rehabilitation in diseases of the cardiovascular system: ed. by IN Makarova. Moscow: GEOTAR-Media, 2010. 304 p. In Russian
12. Zhukova GV, Shikhlyarova AI, Barteneva TA, Barsukova LP, Kostrovitskiy YuV, Petrosyan VI et al. Some strategies of activation therapy using radiations of microwave ranges in experiments on tumor-bearing animals. Cardiometry. 2015;7: 30–35.
13. Logatkina AV, Bondar SS, Terekhov IV, Sobchenko AA. Metabolic effects of low-intensity decimeter physical therapy in arterial hypertension. Bulletin of New Medical Technologies. 2015;22(2):71–77. In Russian
14. Logatkina AV, Bondar SS, Arzhnikov VV, Terekhov IV. Production of cytokines, soluble forms of co molecules and nitric oxide in patients with coronary heart disease on the background of low-intensity microwave treatment. Bulletin of New Medical Technologies. The electronic edition. 2016;1:2–5 [Accessed 2016 Feb 10]. Available from: http://www.medtsu.tula. ru/VNMT/Bulletin/E2016–1/2–5.pdf. In Russian
15. Bondar SS, Logatkina AV, Terekhov IV. Effect of low intensity microwave radiation with a frequency of 1 GHz on the state of the MAPK/SAPK-signaling pathways in mononuclear leukocytes. Biomedical Electronics. 2016;10:28–36. In Russian
16. Terekhov IV, Solodukhin KA, Itskovich VO. Peculiarities of biological action of low-intensity microwave radiation on cytokine production by whole blood cells in community-acquired pneumonia. Cytokines and Inflammation. 2012;11(4):67–72. In Russian
17. Terekhov IV, Khadartcev AA, Bondar SS. State of recuperability signaling pathways in granulocytes of peripheral blood of patients community-acquired pneumonia under the influence of microwave radiation. Voprosy Kurortologii, Fizioterapii i Lechebnoi Fizicheskoi Kultury = The Issues of Balneology, Physiotherapy and Physical Training. 2016;93(3):23–28. doi:10.17116/kurort2016323–28 In Russian
18. Terekhov IV, Solodukhin KA, Nikiforov VS, Gromov MS, Parfenyk VK, Bondar SS. Effects of low-intensity microwave irradiation upon intracellular signaling of mononuclear cells in pneumonia patients. Medical Immunology (Russia). 2012;14(6):541–544. doi:10.15789/1563-0625-2012-6-541-544 In Russian
19. Vlasov VV, Rebrova OYu. Evidence-based medicine: evaluation of therapeutic and preventive interventions. Zamestitel Glavnogo Vracha = Deputy Chief Physician. 2010;(7):53–64. In Russian
20. Moreno PR, Falk E, Palacios IF, Newell JB, Fuster V, Fallon JT. Macrophage infiltration in acute coronary syndromes. Implications for plaque rupture. Circul. 1994;90(2):775–778.
21. De Paoli F, Staels B, Chinetti-Gbaguidi G. Macrophage phenotypes and their modulation in atherosclerosis. Circ J. 2014;78 (8):1775–1781.
22. Koryakina LB, Pivovarov YI, Kurilskaya TE. Dysfunction of the vascular endothelium in arterial hypertension and coronary heart disease (review of literature). Bulletin of Eastern-Siberian Scientific Centre of Siberian Branch of the Russian Academy of medical Sciences. 2013;2–1(90):165–170. In Russian
23. Deanfield JE, Halcox JP, Rabelink TJ. Endothelial function and dysfunction: testing and clinical relevance. Circulation. 2007;115(10):1285–1295.
24. Viollet B, Mounier R, Leclerc J, Yazigi A, Foretz M, Andreelli F. Targeting AMP-activated protein kinase as a novel therapeutic approach for the treatment of metabolic disorders. Diabetes Metab. 2007;33(6):395–402.
25. Logatkina AV, Nikiforov VS, Bondar SS, Terekhov IV. Proinflammatory cytokines and signaling path- ways in peripheral blood mononuclear cells in patients with coronary artery disease. Clinical Medicine. 2017;95(3):238–244. In Russian
Review
For citations:
Khadartcev A.A., Logatkina A.V., Terekhov I.V., Bondar S.S. Metabolic changes in hypertensive patients treated by low-intensity microwave therapy. "Arterial’naya Gipertenziya" ("Arterial Hypertension"). 2018;24(2):206-216. (In Russ.) https://doi.org/10.18705/1607-419X-2018-24-2-206-216